Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance (NCT03057756) | Clinical Trial Compass
CompletedNot Applicable
Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance
Gabon23 participantsStarted 2015-09-11
Plain-language summary
The principal objective is to evaluate a cure rate and number of adverse events of with confirmed multidrug-resistant tuberculosis patient treated with a 9months regimen.
Who can participate
Age range15 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Aged 15 years and above
* Never been treated with second line anti-TB drugs for more than one month,
* Give written consent to participate
* Agree to be hospitalised for at least four months in specialised healthcare
* Willing to adhere to ambulatory directly observed treatment by a healthcare worker;
Exclusion criteria:
* Pregnant during inclusion process
* Presented with altered clinical status condition as judged by the clinician
* Knowing of history of hypersensitivity reaction to any of the drugs to be used
* Baseline ECG does not show a QT space superior to 500ms
* Refusal to participate into study.